My posts are only my own opinion. Do not rely on anyone! Do your own DD until satisfied!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No, not dumped! Someone bought 10mil shares for .0012. At higher price than the ask.
$EMED $$$$
$EMED
$EMED Great news! Check it out!
— Viewmont (@viewmont12) August 9, 2024
*Sales Growth: *Strategic Partnership:
*Wellness Pro Infinityâ„¢: *Financial Improvements:
*Pre-Order Launch: *Market Expansion:https://t.co/xYNfhBaZl6https://t.co/zV2XEFdQ3t
$EMED So Monday if it opens @ .0013, there won't be a gap either!
I thought today would open @ .0011. Also, since, .0011 was the lowest on the ask, but it opened @ .0012, skipping the .0011. Puzzled.
Hello janetcanada, good to see you!
As always. Nice DD!
Un sorriso per te!
Did you notice at the open, it first sold .0012's almost 10,mil shares, when there were .0011 ASK sitting in cue before the .0012. How did that happen.
Look at the first trade at the bottom, 9,999,575 shares sold at .0012 while .0011 was @at the ask.
https://ih.advfn.com/stock-market/USOTC/electromedical-technolog-pk-EMED/trades
$EMED We'll probably lose a zero or two real soon, and with new news / updates from the company / CEO $EMED should take off hard! IMO..
$EMD $$$ Wow, a mistake! But it's in your account as a buy.
Yes big news coming pretty soon. I love the SS.
https://www.otcmarkets.com/stock/EMED/news/story?e&id=2943456
https://www.otcmarkets.com/stock/EMED/security
$EMED $$$
Nice! I've loaded some!
$EMED
*Sales Growth: 17% increase in revenue in year ended 2023 over year ended in 2022.
*Strategic Partnership: Established partnership with Lionheart Health, winner of the Abbvie Allergan Aesthetics ULP Golden Passport Award and is now an official entrant in the $101 million XPRIZE competition.
*Wellness Pro Infinity™: Completed product development showcasing unmatched precision and capabilities with iDNA technology and Digital Synthesis.
*Financial Improvements: Successfully renegotiated creditor agreements toward a potentially more favorable path for current and potential investors.
*Pre-Order Launch: Opened pre-order sign-ups for Wellness Pro Infinity™, with shipping targeted for September-October, and received a large purchase order from Lionheart Health.
*Market Expansion: Onboarded a medical group with 200 sales reps to introduce Wellness Pro Infinity™ to a broad network of medical professionals and clinics across the United States.
*EMED experienced a robust year-over-year increase in revenue of 17% year ended 2023, over year ended 2022, driven by strong demand for our innovative medical devices and strategic initiatives.
https://www.newswire.com/news/electromedical-provides-update-to-shareholders-22382634
$EMED $$$
BULLISH!
$EMED Did great today!
They don't think! Going to open at .0011 tomorrow! IMO.
Not many left at .0011!
$EMED Holding up pretty strong! Tomorrow we open / go higher! IMO.
$EMED Looks like great company based on DD's I did!
$EMED
$EMED Just started! Ground floor! Getting hot already!
— Viewmont (@viewmont12) August 8, 2024
I don't want any! Thank you!
Business Description
We are a bioelectronics manufacturing company and our mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency and vibration as an alternative to pharmaceuticals; and one day, read and modify electrical signals passing along nerves in the body, to restore long-term health. We believe that we do this by delivering innovative solutions providing fast and long lasting pain relief across the broadest range of ailments. We engineer simple-to-use bioelectronics therapy devices, which send a proprietary sequence of electrical signals. We believe our devices have proven to be highly effective over the past decade and have the technological capability to be used in medical research.
$EMED
$EMED Great low float!https://t.co/QbwyG8awWi
— Viewmont (@viewmont12) August 8, 2024
$EMED
$EMED Check it out! A leading innovator in bioelectronic medical devices, is pleased to provide an update to its shareholders, highlighting significant recent achievements and strategic advancements.https://t.co/zV2XEFdidV
— Viewmont (@viewmont12) August 8, 2024
ASII
@ASII_Inc
·
Aug 7
Final draft: We’re exciting to announce that ASII has reached a final agreement to exchange all currently oustanding convertible notes into Preferred Stock with a total 40% overall debt reduction: https://tinyurl.com/4rxm4nvn #OTCMarkets #OTC #PennyStock
Yes that is great news! Glad they decided to take that route!
Already SS is pretty low and very good compared to others on OTC.
https://www.otcmarkets.com/stock/ASII/security
Great news! NO RS!
https://www.otcmarkets.com/stock/ASII/news/story?e&id=2937981
$ASII Oh you're doing great! Thank you!
Bonjour!
$ASII $$$$$$ News always supersedes the charts! Not the other way around as some say!
When news hits, charts could change directions instantly!
Big news will send us way up high!
Patience!
Hello janet! Nice DD!
Probably Kroger will want to settle fast if guilty, and avoid the legal costs!
$ASII Probably Kroger will want to settle!
$ASII $$$ Next news will send ASII way higher! IMO.
$ASII That's good news! New money coming in!
How do people make a living going door to door on different boards just to say something negative? And they're not even involved?
Are they the real scam? Or scum?
$ASII Good open!
$LGCL It is good news, don't know why people panicked!
Lucas GC Limited Announces US$6 Million Share Repurchase Program
Lucas GC Limited
Thu, Aug 8, 2024, 6:00 AM PDT
https://finance.yahoo.com/news/lucas-gc-limited-announces-us-130000000.html
$CDT
$CDT Active pre-market.
— Viewmont (@viewmont12) August 8, 2024
Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor AZD5904 targeting idiopathic male infertility
$CDT
$CDT Active pre-market.
— Viewmont (@viewmont12) August 8, 2024
Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor AZD5904 targeting idiopathic male infertility
This might close at the high of day?
We have the hot news coming! So whatever shares I can get!
ASII From the CEO!
@ASII_Inc Aug 6
Stay tuned for more company updates coming later this week. Big things are on the horizon! 🚀 #CompanyNews #StayTuned
$ASII CEO says on X.
@ASII_Inc Aug 6
Stay tuned for more company updates coming later this week. Big things are on the horizon! 🚀 #CompanyNews #StayTuned
That's an excellent news! Plus NO RS! Plus news from X.
@ASII_Inc Aug 6
Stay tuned for more company updates coming later this week. Big things are on the horizon!